December 23, 2024

Trump Team Targets Immediate WHO Exit, Experts Say

"I have it on good authority that he plans to withdraw, probably on Day One or very early in his administration."

Reuters

December 20, 2024

FDA Approves New Cystic Fibrosis Drug

Vertex Pharmaceuticals' groundbreaking next-generation treatment for cystic fibrosis, Alyftrek, has been approved by the FDA, promising to revolutionize the management of this rare genetic disease.

Reuters

December 18, 2024

Larotrectinib in Newly Diagnosed Infantile Fibrosarcoma and Other Pediatric NTRK Fusion–Positive Solid Tumors

In a Children’s Oncology Group study (ADVL1823) reported in Journal of Clinical Oncology, Laetsch et al evaluated the role of larotrectinib in patients with newly diagnosed infantile fibrosarcoma and ...

The ASCO Post

December 18, 2024

Does Anger at Health Care Drive Change?

In-depth exploration of public anger towards the American health care system throughout history, potential for change, and Hollywood's portrayal of health insurance-related events.

KFF Health News

December 18, 2024

FDA Approves Mesoblast's Therapy for GVHD

FDA approves Mesoblast's cell therapy for treating graft-versus-host disease after stem cell or bone marrow transplants.

Reuters

December 16, 2024

Probiotics' Limits Revealed in Major Review

"Current evidence does not support the notion that probiotics can restore the microbiota to its pre-antibiotic state."

Conexiant

December 16, 2024

Study Finds New Sexual Transmission Disease Risks

Review expands list of viruses persisting in human semen from 9 to 22.

Conexiant

December 16, 2024

FDA 6-Month Drug Pipeline

A pipeline of novel drugs awaits FDA review through the first half of 2025.

Conexiant

December 16, 2024

New Drug Cuts Steroid Need in CAH

The FDA has approved crinecerfont (Crenessity) to manage androgen levels in classic congenital adrenal hyperplasia in individuals aged 4 or older. Find out more at FDA.

Conexiant